tiprankstipranks
Optimi Health Expands Global Psychedelic Supply
Company Announcements

Optimi Health Expands Global Psychedelic Supply

Optimi Health (TSE:OPTI) has released an update.

Don't Miss our Black Friday Offers:

Optimi Health Corp., a GMP psychedelics pharmaceutical manufacturer, has successfully shipped its first batch of MDMA to Israel and secured vital Canadian export authorizations, marking a significant expansion in its global operations. The move enhances the company’s ability to supply controlled substances for scientific and therapeutic use worldwide. Additionally, Optimi has engaged Oak Hill Financial Inc. to strengthen investor relations and promote its corporate milestones within the investment community.

For further insights into TSE:OPTI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskOptimi Health’s MDMA Success in Australia
TipRanks Canadian Auto-Generated NewsdeskOptimi Health Advances Psilocybin Trial for Depression
TipRanks Canadian Auto-Generated NewsdeskOptimi Health Expands Global Reach with Psychedelic Treatments
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App